| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.10B | -3.0% | +0.7% |
| Gross Profit | $1.14B | -3.4% | -2.6% |
| R&D Expense | $183.0M | -3.2% | -3.2% |
| SG&A Expense | $780.0M | +1.0% | +11.3% |
| Operating Income | $1.69B | +689.7% | +514.5% |
| Pre-tax Income | $1.51B | +1369.9% | +806.6% |
| Income Tax | $248.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.64B | +233.7% | +112.7% |
| Accounts Receivable | $1.02B | -4.3% | -7.8% |
| Inventory | $1.05B | +9.0% | +10.1% |
| Current Assets | $4.41B | +37.4% | +31.4% |
| Total Assets | $13.97B | -7.3% | -5.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $274.0M | — | — |
| Capital Expenditures | $316.0M | — | — |
| Investing Cash Flow | $3.54B | — | — |
| Financing Cash Flow | -$2.94B | — | — |
| Free Cash Flow | -$42.0M | — | — |
| +1807.7% |
| +451.1% |
| Net Income | $1.27B | +1306.7% | +937.7% |
| EPS (Basic) | $7.26 | +1296.2% | +937.1% |
| EPS (Diluted) | $7.22 | +1315.7% | +931.4% |
| $2.94B |
| +12.1% |
| +1.2% |
| Long-term Debt | $5.14B | -34.3% | -36.7% |
| Total Liabilities | $8.99B | -21.4% | -22.2% |
| Stockholders' Equity | $4.99B | +36.8% | +56.2% |